Your daily source for AI news, tools reviews, and practical guides to artificial intelligence
Converge Bio, an AI-focused drug discovery startup, has closed a $25 million Series A funding round led by Bessemer Venture Partners, attracting investments from prominent figures at Meta, OpenAI, and Wiz.
Smart Health Asia, launching in Singapore this July, is set to become the leading event for digital health innovation in the region, spotlighting how AI and technology are revolutionizing healthcare delivery and patient outcomes.
Converge Bio, an AI-powered drug discovery startup, has successfully raised $25 million in a Series A funding round led by Bessemer Venture Partners, with support from key executives at Meta, OpenAI, and Wiz.